Science Rising adoption of Galleri testing and expanded strategic alliances result in Grail revising its cash burn estimate for 2025 to $310 million. , and Administrator 2025 August 28
personal-finance Highest Medicine Costs in Europe: Rankings and Underlying Factors Falling Short Compared to the U.S. , and Administrator 2025 May 16
